2m 2m 2m 2m 2m 2m 2m
AIM IMMUNOTECH (AIM)
NYSE
$0.25+$0.0004 (+0.16%)
Price as of Aug 03, 2026 7:30 AM EDT- $7.0MMarket Cap
- -91.03%1-Year Change
- BiotechnologyIndustry
AIM IMMUNOTECH (AIM)
$0.25+$0.0004 (+0.16%)
AIM | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.25 | ||
Change | +$0.02 (+7.91%) | ||
Open | $0.24 | ||
High | $0.28 | ||
Low | $0.24 | ||
Previous Close | $0.23 | ||
Volume | 3,653,101 | ||
30-Day Average Volume | 692,195 | ||
1-Week Change | 1.85% | ||
1-Month Change | -10.70% | ||
1-Year Change | -91.03% | ||
3-Year Change | -59.19% | ||
5-Year Change | -87.85% | ||
Fundamentals | |||
Shares Outstanding | 27.7M | ||
Total Assets | $8.6M | ||
Market Cap | $7.0M | ||
Enterprise Value | $5.4M | ||
Period: QTR TTM FY | |||
Revenue | $22,000.00 | ||
Net Income | N/A | ||
Free Cash Flow | -$2.7M | ||
EBIT | $0.00 | ||
EBITDA | $34,000.00 | ||
Net Working Capital | $69,000.00 | ||
EPS | -$0.69 | ||
Enterprise Value/EBITDA | 160 | ||
Enterprise Value/Revenue | 247 | ||
P/B | 3 | ||
P/E | -0 | ||
PEG | N/A | ||
Price/Free Cash Flow | -3 | ||
Price/Operating Cash Flow | -3 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1001 : 1000 | ||
Last Split Date | 01/09/2026 | ||
Earnings & Revenue